Patent · US Active

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

US9045475B2 · kind B2 · utility

11Cited by

31References

2Claims

0Family size

Assignees

Abb Vie Inc. · US
Genentech, Inc. · US
THE WALTER AND ELIZA INSTITUTE OF MEDICAL RESEARCH · AU

Inventors

Steven W. Elmore · Northbrook, US
Andrew J. Souers · Libertyville, US
Zhi-Fu Tao · Vernon Hills, US

Key dates

Filing date	Mar 14, 2013
Grant date	Jun 2, 2015
Priority date	—
Expiry date	Mar 14, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.